Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors.

Golinelli G, Grisendi G, Prapa M, Bestagno M, Spano C, Rossignoli F, Bambi F, Sardi I, Cellini M, Horwitz EM, Feletti A, Pavesi G, Dominici M.

Cancer Gene Ther. 2018 Nov 22. doi: 10.1038/s41417-018-0062-x. [Epub ahead of print]

PMID:
30464207
2.

Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions.

Bortolotti D, Rossignoli F, Rotola A, Campioni D, Cultrera R, Grisendi G, Dominici M, Rizzo R.

Hum Immunol. 2018 Nov;79(11):800-808. doi: 10.1016/j.humimm.2018.08.006. Epub 2018 Aug 14.

PMID:
30118778
3.

In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.

Guiho R, Biteau K, Grisendi G, Chatelais M, Brion R, Taurelle J, Renault S, Heymann D, Dominici M, Redini F.

Cytotherapy. 2018 Aug;20(8):1037-1045. doi: 10.1016/j.jcyt.2018.06.013. Epub 2018 Aug 6.

PMID:
30093324
4.

Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy.

Rossignoli F, Grisendi G, Spano C, Golinelli G, Recchia A, Rovesti G, Orsi G, Veronesi E, Horwitz EM, Dominici M.

Cancer Gene Ther. 2018 Jun 29. doi: 10.1038/s41417-018-0034-1. [Epub ahead of print]

PMID:
29955091
5.

Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro.

Checchi M, Bertacchini J, Grisendi G, Smargiassi A, Sola A, Messori M, Palumbo C.

Biomedicines. 2017 Dec 25;6(1). pii: E3. doi: 10.3390/biomedicines6010003.

6.

Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression.

Baglio SR, Lagerweij T, Pérez-Lanzón M, Ho XD, Léveillé N, Melo SA, Cleton-Jansen AM, Jordanova ES, Roncuzzi L, Greco M, van Eijndhoven MAJ, Grisendi G, Dominici M, Bonafede R, Lougheed SM, de Gruijl TD, Zini N, Cervo S, Steffan A, Canzonieri V, Martson A, Maasalu K, Köks S, Wurdinger T, Baldini N, Pegtel DM.

Clin Cancer Res. 2017 Jul 15;23(14):3721-3733. doi: 10.1158/1078-0432.CCR-16-2726. Epub 2017 Jan 4. Erratum in: Clin Cancer Res. 2018 Feb 1;24(3):724.

7.

Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.

Petrachi T, Romagnani A, Albini A, Longo C, Argenziano G, Grisendi G, Dominici M, Ciarrocchi A, Dallaglio K.

Oncotarget. 2017 Jan 24;8(4):6914-6928. doi: 10.18632/oncotarget.14321.

8.

In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.

Latella MC, Di Salvo MT, Cocchiarella F, Benati D, Grisendi G, Comitato A, Marigo V, Recchia A.

Mol Ther Nucleic Acids. 2016 Nov 22;5(11):e389. doi: 10.1038/mtna.2016.92.

9.

Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Conforti A, Starc N, Biagini S, Tomao L, Pitisci A, Algeri M, Sirleto P, Novelli A, Grisendi G, Candini O, Carella C, Dominici M, Locatelli F, Bernardo ME.

Oncotarget. 2016 Nov 22;7(47):77416-77429. doi: 10.18632/oncotarget.12678.

10.

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.

Fiorcari S, Maffei R, Audrito V, Martinelli S, Ten Hacken E, Zucchini P, Grisendi G, Potenza L, Luppi M, Burger JA, Deaglio S, Marasca R.

Oncotarget. 2016 Oct 4;7(40):65968-65981. doi: 10.18632/oncotarget.11782.

11.

Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.

Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N, Kusuzaki K, Chano T, Grisendi G, Dominici M, De Milito A, Baldini N.

Oncotarget. 2016 Sep 27;7(39):63408-63423. doi: 10.18632/oncotarget.11503.

12.

TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.

Guiho R, Biteau K, Grisendi G, Taurelle J, Chatelais M, Gantier M, Heymann D, Dominici M, Redini F.

Int J Cancer. 2016 Dec 15;139(12):2802-2811. doi: 10.1002/ijc.30402. Epub 2016 Sep 12.

13.

CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.

Saltari A, Truzzi F, Quadri M, Lotti R, Palazzo E, Grisendi G, Tiso N, Marconi A, Pincelli C.

J Invest Dermatol. 2016 Oct;136(10):2049-2058. doi: 10.1016/j.jid.2016.05.116. Epub 2016 Jun 18.

14.

Tumor Stroma Manipulation By MSC.

Grisendi G, Spano C, Rossignoli F, D Souza N, Golinelli G, Fiori A, Horwitz EM, Guarneri V, Piacentini F, Paolucci P, Dominici M.

Curr Drug Targets. 2016;17(10):1111-26. Review.

PMID:
26953248
15.

Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.

Perut F, Carta F, Bonuccelli G, Grisendi G, Di Pompo G, Avnet S, Sbrana FV, Hosogi S, Dominici M, Kusuzaki K, Supuran CT, Baldini N.

Expert Opin Ther Targets. 2015;19(12):1593-605. doi: 10.1517/14728222.2016.1086339. Epub 2015 Sep 10.

PMID:
26357839
16.

A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.

Prapa M, Caldrer S, Spano C, Bestagno M, Golinelli G, Grisendi G, Petrachi T, Conte P, Horwitz EM, Campana D, Paolucci P, Dominici M.

Oncotarget. 2015 Sep 22;6(28):24884-94. doi: 10.18632/oncotarget.4670.

17.

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.

D'souza N, Rossignoli F, Golinelli G, Grisendi G, Spano C, Candini O, Osturu S, Catani F, Paolucci P, Horwitz EM, Dominici M.

BMC Med. 2015 Aug 12;13:186. doi: 10.1186/s12916-015-0426-0. Review.

18.

Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.

Ferrari-Amorotti G, Chiodoni C, Shen F, Cattelani S, Soliera AR, Manzotti G, Grisendi G, Dominici M, Rivasi F, Colombo MP, Fatatis A, Calabretta B.

Neoplasia. 2014 Dec;16(12):1047-58. doi: 10.1016/j.neo.2014.10.006.

19.

Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis.

Candini O, Spano C, Murgia A, Grisendi G, Veronesi E, Piccinno MS, Ferracin M, Negrini M, Giacobbi F, Bambi F, Horwitz EM, Conte P, Paolucci P, Dominici M.

Stem Cells. 2015 Mar;33(3):939-50. doi: 10.1002/stem.1897.

20.

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.

Grisendi G, Spano C, D'souza N, Rasini V, Veronesi E, Prapa M, Petrachi T, Piccinno S, Rossignoli F, Burns JS, Fiorcari S, Granchi D, Baldini N, Horwitz EM, Guarneri V, Conte P, Paolucci P, Dominici M.

Stem Cells. 2015 Mar;33(3):859-69. doi: 10.1002/stem.1903.

Supplemental Content

Loading ...
Support Center